Natural Killer Cell Therapy Industry Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapy.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Natural Killer Cell Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Natural Killer Cell Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Natural Killer Cell Therapy segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Natural Killer Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Natural Killer Cell Therapy market.
Natural Killer Cell Therapy Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Natural Killer Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Natural Killer Cell Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Natural Killer Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The Natural Killer Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Nektar Therapeutics
- Innate Pharma SA
- Affimed
- Chipscreen Biosciences
- Glycostem Therapeutics
- Fate Therapeutics
- Dragonfly Therapeutics
- Kiadis Pharma
- Nkarta Therapeutics
- NantKwest
Global markets are presented by Natural Killer Cell Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Natural Killer Cell Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Natural Killer Cell Therapy segment by Type
- NK Cell Therapies
- NK Cell Directed Antibodies
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Natural Killer Cell Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Natural Killer Cell Therapy market.
Natural Killer Cell Therapy Segment by Application
- Cancer
- Gastrointestinal Diseases
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Natural Killer Cell Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Natural Killer Cell Therapy industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Natural Killer Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Natural Killer Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cancer
2.3.3 Gastrointestinal Diseases
2.3.4 Others
2.4 Assumptions and Limitations
3 NATURAL KILLER CELL THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2018-2023)
3.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2023-2028)
4 NATURAL KILLER CELL THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2018-2023)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Natural Killer Cell Therapy Market Perspective (2018-2029)
5.2 Global Natural Killer Cell Therapy Growth Trends by Region
5.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2018-2023)
5.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2024-2029)
5.3 Natural Killer Cell Therapy Market Dynamics
5.3.1 Natural Killer Cell Therapy Industry Trends
5.3.2 Natural Killer Cell Therapy Market Drivers
5.3.3 Natural Killer Cell Therapy Market Challenges
5.3.4 Natural Killer Cell Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Natural Killer Cell Therapy Players by Revenue
6.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2018-2023)
6.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2018-2023)
6.2 Global Natural Killer Cell Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
6.4 Global Natural Killer Cell Therapy Players, Product Type & Application
6.5 Global Natural Killer Cell Therapy Players, Date of Enter into This Industry
6.6 Global Natural Killer Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Natural Killer Cell Therapy Market Size (2018-2029)
7.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Natural Killer Cell Therapy Market Size by Country (2018-2023)
7.4 North America Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Natural Killer Cell Therapy Market Size (2018-2029)
8.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Natural Killer Cell Therapy Market Size by Country (2018-2023)
8.4 Europe Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2018-2029)
9.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Natural Killer Cell Therapy Market Size (2018-2029)
10.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Natural Killer Cell Therapy Market Size by Country (2018-2023)
10.4 Latin America Natural Killer Cell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2018-2029)
11.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Detail
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Detail
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Detail
11.3.2 Affimed Business Overview
11.3.3 Affimed Natural Killer Cell Therapy Introduction
11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Detail
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Detail
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.6.5 Fate Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Detail
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Detail
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.8.5 Kiadis Pharma Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Detail
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.9.5 Nkarta Therapeutics Recent Development
11.10 NantKwest
11.10.1 NantKwest Company Detail
11.10.2 NantKwest Business Overview
11.10.3 NantKwest Natural Killer Cell Therapy Introduction
11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.10.5 NantKwest Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Natural Killer Cell Therapy by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
2.3 Natural Killer Cell Therapy by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Cancer
2.3.3 Gastrointestinal Diseases
2.3.4 Others
2.4 Assumptions and Limitations
3 NATURAL KILLER CELL THERAPY BREAKDOWN DATA BY TYPE
3.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2018-2023)
3.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2023-2028)
4 NATURAL KILLER CELL THERAPY BREAKDOWN DATA BY APPLICATION
4.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2018-2023)
4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Natural Killer Cell Therapy Market Perspective (2018-2029)
5.2 Global Natural Killer Cell Therapy Growth Trends by Region
5.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2018-2023)
5.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2024-2029)
5.3 Natural Killer Cell Therapy Market Dynamics
5.3.1 Natural Killer Cell Therapy Industry Trends
5.3.2 Natural Killer Cell Therapy Market Drivers
5.3.3 Natural Killer Cell Therapy Market Challenges
5.3.4 Natural Killer Cell Therapy Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Natural Killer Cell Therapy Players by Revenue
6.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2018-2023)
6.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2018-2023)
6.2 Global Natural Killer Cell Therapy Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Natural Killer Cell Therapy Head office and Area Served
6.4 Global Natural Killer Cell Therapy Players, Product Type & Application
6.5 Global Natural Killer Cell Therapy Players, Date of Enter into This Industry
6.6 Global Natural Killer Cell Therapy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Natural Killer Cell Therapy Market Size (2018-2029)
7.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Natural Killer Cell Therapy Market Size by Country (2018-2023)
7.4 North America Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Natural Killer Cell Therapy Market Size (2018-2029)
8.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Natural Killer Cell Therapy Market Size by Country (2018-2023)
8.4 Europe Natural Killer Cell Therapy Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2018-2029)
9.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2018-2023)
9.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Natural Killer Cell Therapy Market Size (2018-2029)
10.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Natural Killer Cell Therapy Market Size by Country (2018-2023)
10.4 Latin America Natural Killer Cell Therapy Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2018-2029)
11.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2018-2023)
11.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Detail
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.1.5 Nektar Therapeutics Recent Development
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Detail
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.2.5 Innate Pharma SA Recent Development
11.3 Affimed
11.3.1 Affimed Company Detail
11.3.2 Affimed Business Overview
11.3.3 Affimed Natural Killer Cell Therapy Introduction
11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.3.5 Affimed Recent Development
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Detail
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.4.5 Chipscreen Biosciences Recent Development
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Detail
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.5.5 Glycostem Therapeutics Recent Development
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Company Detail
11.6.2 Fate Therapeutics Business Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction
11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.6.5 Fate Therapeutics Recent Development
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Detail
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.7.5 Dragonfly Therapeutics Recent Development
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Detail
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.8.5 Kiadis Pharma Recent Development
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Company Detail
11.9.2 Nkarta Therapeutics Business Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction
11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.9.5 Nkarta Therapeutics Recent Development
11.10 NantKwest
11.10.1 NantKwest Company Detail
11.10.2 NantKwest Business Overview
11.10.3 NantKwest Natural Killer Cell Therapy Introduction
11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2017-2022)
11.10.5 NantKwest Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
